Teneligliptin
-
Catalog numberB1932-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name((2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone; Tenelia
-
DescriptionTeneligliptin is a potent DPP-4 (dipeptidylpeptidase-4) inhibitor, that competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC₅₀s of approximately 1 nM. Useful drug for treatment of type 2 diabetes mellitus (T2DM).
-
CAS Number760937-92-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₃₀N6₆OS
-
Molecular Weight426.58
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent DPP-4 (dipeptidylpeptidase-4) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID11949652
-
SMILESCC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5
-
InChiInChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1
-
InChi KeyWGRQANOPCQRCME-PMACEKPBSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameTeneligliptin
-
Alternative nameTeneligliptin
-